Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (251-260 of 532) with videos related to

Pageof 54
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2006
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeysS S Negus, N K Mello, B E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2012
Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transportersRichard B Rothman, John S Partilla, Michael H Baumann, et al.
Life Sciences|January 1, 1990
Pseudoallosteric modulation by (+)-MK801 of NMDA-coupled phencyclidine binding sitesA A Reid, J A Monn, A E Jacobson, et al.
Journal of Substance Abuse Treatment|May 1, 1997
Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case studyD C Ohuoha, J A Maxwell, L E Thomson, et al.
Annals of the New York Academy of Sciences|November 21, 2000
Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaineM H Baumann, J P Pablo, S F Ali, et al.
Life Sciences|January 1, 1995
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninD C Mash, J K Staley, M H Baumann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011
X-ray crystal structures elucidate the nucleotidyl transfer reaction of transcript initiation using two nucleotidesMichael L Gleghorn, Elena K Davydova, Ritwika Basu, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1996
Endocrine responses during acute nicotine withdrawalW B Pickworth, M H Baumann, R V Fant, et al.
Peptides|November 1, 1992
Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneityH Xu, J S Partilla, B R de Costa, et al.
Bioorganic & Medicinal Chemistry|April 27, 2013
Probes for narcotic receptor mediated phenomena. 47. Novel C4a- and N-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-olsMalliga R Iyer, Richard B Rothman, Christina M Dersch, et al.
Pageof 54

Showing results (251-260 of 532) with videos related to

Sort By:
Pageof 54
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2006
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeysS S Negus, N K Mello, B E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2012
Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transportersRichard B Rothman, John S Partilla, Michael H Baumann, et al.
Life Sciences|January 1, 1990
Pseudoallosteric modulation by (+)-MK801 of NMDA-coupled phencyclidine binding sitesA A Reid, J A Monn, A E Jacobson, et al.
Journal of Substance Abuse Treatment|May 1, 1997
Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case studyD C Ohuoha, J A Maxwell, L E Thomson, et al.
Annals of the New York Academy of Sciences|November 21, 2000
Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaineM H Baumann, J P Pablo, S F Ali, et al.
Life Sciences|January 1, 1995
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninD C Mash, J K Staley, M H Baumann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011
X-ray crystal structures elucidate the nucleotidyl transfer reaction of transcript initiation using two nucleotidesMichael L Gleghorn, Elena K Davydova, Ritwika Basu, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1996
Endocrine responses during acute nicotine withdrawalW B Pickworth, M H Baumann, R V Fant, et al.
Peptides|November 1, 1992
Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneityH Xu, J S Partilla, B R de Costa, et al.
Bioorganic & Medicinal Chemistry|April 27, 2013
Probes for narcotic receptor mediated phenomena. 47. Novel C4a- and N-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-olsMalliga R Iyer, Richard B Rothman, Christina M Dersch, et al.
Pageof 54